NovaBay Pharmaceuticals, Inc. Announces Board and Committee Changes
April 03, 2020 at 04:33 pm EDT
Share
On March 31, 2020, Ms. Gail Maderis informed NovaBay Pharmaceuticals, Inc. of her resignation as a member of the Company’s Board of Directors (the “Board”), with such resignation to be effective immediately. The Board appointed an existing independent Board member, Ms. Swan Sit, to fulfill the vacancies left on the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee as a result of Ms. Maderis’ resignation. Further, the Board appointed Dr. Yenyou (Jeff) Zheng to serve as both the Chairman of the Audit Committee and as the Audit Committee Financial Expert, also resulting from Ms. Maderis’ resignation from those roles. Ms. Maderis did not resign as a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The Board accepted the resignation of Ms. Maderis and reduced the size of the Board from seven to six members effective with her resignation.
NovaBay Pharmaceuticals, Inc. is a pharmaceutical company that develops and sells consumer products for the eyecare and skincare markets. The Company's lead product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have antimicrobial properties as it removes foreign material, such as microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is formulated with its form of hypochlorous acid and is cleared by the United States Food and Drug Administration (FDA) for sale in the United States. Its other eyecare products offered under the Avenova eyecare brand include Novawipes by Avenova, Avenova Lubricant Eye Drops, Avenova Moist Heating Eye Compress and the i-Chek. Avenova Spray is available both over-the-counter and as a prescription. Avenova Spray is also available at optometrists and ophthalmologists offices; at national pharmacy chains across all over 50 states, and through its Partner Pharmacy Program.
NOVABAY PHARMACEUTICALS 
